RAFAEL HOLDINGS, INC. Payments to Acquire Short-term Investments
RAFAEL HOLDINGS, INC. (RFL) reported Payments to Acquire Short-term Investments of $3.00 million for the 12-month period ending 2023-07-31, per its 10-K filed 2023-10-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2023-10-30
- RAFAEL HOLDINGS, INC. payments to acquire short-term investments for the quarter ending 2022-04-30 was $26.00K, a 89.60% decline year-over-year.
- RAFAEL HOLDINGS, INC. payments to acquire short-term investments for the quarter ending 2022-01-31 was $31.00K.
- RAFAEL HOLDINGS, INC. payments to acquire short-term investments for the quarter ending 2021-10-31 was $29.00K.
- RAFAEL HOLDINGS, INC. payments to acquire short-term investments for the quarter ending 2021-07-31 was $750.00K.
- RAFAEL HOLDINGS, INC. payments to acquire short-term investments for fiscal 2023 was $3.00M.
- RAFAEL HOLDINGS, INC. payments to acquire short-term investments for fiscal 2021 was $2.00M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2023-07-31 | $3.00M 10-K · filed 2023-10-30 | |||
| 2022-04-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $57.00K derived: sum of 2 quarters · filed 2023-06-13 | $86.00K 10-Q · filed 2023-06-13 | $836.00K derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-01-31 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $60.00K 10-Q · filed 2023-03-14 | $810.00K derived: sum of 3 quarters · filed 2023-03-14 | $1.06M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-10-31 | $29.00K 10-Q · filed 2022-12-13 | $779.00K derived: sum of 2 quarters · filed 2022-12-13 | $1.03M derived: sum of 3 quarters · filed 2022-12-13 | |
| 2021-07-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $1.00M derived: sum of 2 quarters · filed 2022-10-31 | $2.00M 10-K · filed 2022-10-31 | |
| 2021-04-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $1.25M 10-Q · filed 2022-06-14 | ||
| 2021-01-31 | $1.00M 10-Q · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |